Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity.

IF 2 Q3 ONCOLOGY
Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, Micaela Kalani Roy, Amy Argabright, Julie A Reisz, Angelo D'Alessandro, Meher P Boorgula, Andrew Goodspeed, Mike Bickerdike, Benjamin G Bitler, Jennifer K Richer
{"title":"Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity.","authors":"Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, Micaela Kalani Roy, Amy Argabright, Julie A Reisz, Angelo D'Alessandro, Meher P Boorgula, Andrew Goodspeed, Mike Bickerdike, Benjamin G Bitler, Jennifer K Richer","doi":"10.1158/2767-9764.CRC-24-0272","DOIUrl":null,"url":null,"abstract":"<p><strong>Significance: </strong>TDO2 is more highly expressed than the nonhomologous TRP-catabolizing enzyme IDO1 in TNBC. We find that TDO2 knockdown can lead to a compensatory increase in IDO1. Therefore, we tested a newly developed TDO2/IDO1 dual inhibitor and found that it decreases TRP catabolism, anchorage-independent survival, and invasive capacity.</p>","PeriodicalId":72516,"journal":{"name":"Cancer research communications","volume":" ","pages":"2699-2713"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484926/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2767-9764.CRC-24-0272","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Significance: TDO2 is more highly expressed than the nonhomologous TRP-catabolizing enzyme IDO1 in TNBC. We find that TDO2 knockdown can lead to a compensatory increase in IDO1. Therefore, we tested a newly developed TDO2/IDO1 dual inhibitor and found that it decreases TRP catabolism, anchorage-independent survival, and invasive capacity.

阻止色氨酸分解可降低三阴性乳腺癌的侵袭能力
与二维培养的相同细胞相比,不依赖锚的三阴性乳腺癌(TNBC)细胞表现出色氨酸(TRP)分解酶色氨酸 2,3-二氧合酶 2(TDO2)水平的升高。对 13C11-TRP 的追踪结果表明,不固定培养和/或激活活化 B 的核因子卡帕-轻链-增强因子(NFκB)的炎症细胞因子会增加 TRP 的分解和下游分解物(如犬尿氨酸(KYN))的产生,从而激活芳基烃受体(AhR)。TDO2在TNBC细胞系中的表达是异质性的。为了确定TDO2的功能,研究人员进行了药物抑制和基因操作。TDO2敲除后,吲哚胺2,3-二氧合酶1(IDO1)--一种非同源的TRP分解酶--出现了代偿性增加,这表明要想可靠地阻断TRP分解,必须对这两种酶进行双重抑制。因此,我们测试了新开发的TDO2/IDO1双重抑制剂AT-0174,发现它能有效抑制TNBC的TRP分解。此外,AT-0174或AhR抑制剂能显著降低TNBC的锚碇依赖性存活率、侵袭能力以及间质基因和蛋白的表达,而外源性KYN能通过AhR介导的ZEB1表达增加侵袭能力。因此,TDO2/IDO1的双重抑制可能对TNBC的进展有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信